Tags

Type your tag names separated by a space and hit enter

COVID-19 vaccination campaign in Nepal, emerging UK variant and futuristic vaccination strategies to combat the ongoing pandemic.
Travel Med Infect Dis. 2021 May-Jun; 41:102037.TM

Abstract

With the emergence of the new variants of concern (VOC) of the SARS-CoV-2, the efficacy of certain vaccines against them requires further research and considerations for future scenarios of COVID-19 vaccination. The vaccines' lack of efficacy against VOC will pose at risk to the vaccinated population and is a public health threat. In this commentary, we discuss Nepal's recent experiences and expectations regarding the confirmation of VOC B.1.1.7 from the United Kingdom in the country.

Authors+Show Affiliations

Tribhuvan University Teaching Hospital, Institute of Medicine, Kathmandu, Nepal; National Public Health Laboratory, Kathmandu, Nepal.Department of Pharmaceutical and Health Service Research, Nepal Health Research and Innovation Foundation, Lalitpur, Nepal.School of Pharmacy, Monash University Malaysia, Jalan Lagoon Selatan, 47500, Bandar Sunway, Selangor Darul Ehsan, Malaysia.School of Pharmacy, Monash University Malaysia, Jalan Lagoon Selatan, 47500, Bandar Sunway, Selangor Darul Ehsan, Malaysia.Department of Veterinary Microbiology and Immunology, College of Veterinary Sciences, Uttar Pradesh Pandit Deen Dayal Upadhyaya Pashu Chikitsa Vigyan Vishwavidyalaya Evam Go Anusandhan Sansthan (DUVASU), Mathura, 281001, India.Department of Chemistry, Government College of Engineering, Keonjhar, Odisha, India.Division of Pathology, ICAR-Indian Veterinary Research Institute, Izatnagar, Bareilly, 243122, Uttar Pradesh, India. Electronic address: kdhama@rediffmail.com.Grupo de Investigación Biomedicina, Faculty of Medicine, Fundacion Universitaria Autonoma de Las Americas, Pereira, Risaralda, Colombia; School of Medicine, Universidad Privada Franz Tamayo (UNIFRANZ), Cochabamba, Bolivia. Electronic address: alfonso.rodriguez@uam.edu.co.

Pub Type(s)

Journal Article

Language

eng

PubMed ID

33781945

Citation

Sah, Ranjit, et al. "COVID-19 Vaccination Campaign in Nepal, Emerging UK Variant and Futuristic Vaccination Strategies to Combat the Ongoing Pandemic." Travel Medicine and Infectious Disease, vol. 41, 2021, p. 102037.
Sah R, Khatiwada AP, Shrestha S, et al. COVID-19 vaccination campaign in Nepal, emerging UK variant and futuristic vaccination strategies to combat the ongoing pandemic. Travel Med Infect Dis. 2021;41:102037.
Sah, R., Khatiwada, A. P., Shrestha, S., Bhuvan, K. C., Tiwari, R., Mohapatra, R. K., Dhama, K., & Rodriguez-Morales, A. J. (2021). COVID-19 vaccination campaign in Nepal, emerging UK variant and futuristic vaccination strategies to combat the ongoing pandemic. Travel Medicine and Infectious Disease, 41, 102037. https://doi.org/10.1016/j.tmaid.2021.102037
Sah R, et al. COVID-19 Vaccination Campaign in Nepal, Emerging UK Variant and Futuristic Vaccination Strategies to Combat the Ongoing Pandemic. Travel Med Infect Dis. 2021 May-Jun;41:102037. PubMed PMID: 33781945.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - COVID-19 vaccination campaign in Nepal, emerging UK variant and futuristic vaccination strategies to combat the ongoing pandemic. AU - Sah,Ranjit, AU - Khatiwada,Asmita Priyadarshini, AU - Shrestha,Sunil, AU - Bhuvan,K C, AU - Tiwari,Ruchi, AU - Mohapatra,Ranjan K, AU - Dhama,Kuldeep, AU - Rodriguez-Morales,Alfonso J, Y1 - 2021/03/27/ PY - 2021/02/19/received PY - 2021/03/15/revised PY - 2021/03/22/accepted PY - 2021/3/31/pubmed PY - 2021/5/20/medline PY - 2021/3/30/entrez KW - COVID-19 KW - Nepal KW - SARS-CoV-2 KW - Vaccination KW - Variants of concern SP - 102037 EP - 102037 JF - Travel medicine and infectious disease JO - Travel Med Infect Dis VL - 41 N2 - With the emergence of the new variants of concern (VOC) of the SARS-CoV-2, the efficacy of certain vaccines against them requires further research and considerations for future scenarios of COVID-19 vaccination. The vaccines' lack of efficacy against VOC will pose at risk to the vaccinated population and is a public health threat. In this commentary, we discuss Nepal's recent experiences and expectations regarding the confirmation of VOC B.1.1.7 from the United Kingdom in the country. SN - 1873-0442 UR - https://www.unboundmedicine.com/medline/citation/33781945/COVID_19_vaccination_campaign_in_Nepal_emerging_UK_variant_and_futuristic_vaccination_strategies_to_combat_the_ongoing_pandemic_ L2 - https://linkinghub.elsevier.com/retrieve/pii/S1477-8939(21)00078-8 DB - PRIME DP - Unbound Medicine ER -